BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16082600)

  • 21. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.
    Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T
    J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas.
    Nakagohri T; Asano T; Kenmochi T; Urashima T; Ochiai T
    World J Surg; 2002 Sep; 26(9):1166-9. PubMed ID: 12045867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroral pancreatoscopy using the SpyGlass system for the assessment of intraductal papillary mucinous neoplasm of the pancreas.
    Nagayoshi Y; Aso T; Ohtsuka T; Kono H; Ideno N; Igarashi H; Takahata S; Oda Y; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):410-7. PubMed ID: 24123930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection.
    Gaitanidis A; Alevizakos M; Tsaroucha A; Tsalikidis C; Simopoulos C; Pitiakoudis M
    Eur J Surg Oncol; 2018 May; 44(5):693-699. PubMed ID: 29426780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraductal papillary mucinous neoplasms of the pancreas.
    Tanaka M
    Pancreas; 2014 Nov; 43(8):1136-40. PubMed ID: 25333396
    [No Abstract]   [Full Text] [Related]  

  • 27. Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity.
    Andrejevic-Blant S; Kosmahl M; Sipos B; Klöppel G
    Virchows Arch; 2007 Nov; 451(5):863-9. PubMed ID: 17899180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.
    Nakagohri T; Konishi M; Inoue K; Tanizawa Y; Kinoshita T
    Hepatogastroenterology; 2004; 51(59):1480-3. PubMed ID: 15362782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.
    Yogi T; Hijioka S; Imaoka H; Mizuno N; Hara K; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Niwa Y; Yoshimura K; Bhatia V; Fujita J; Yamao K
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):757-65. PubMed ID: 26148131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intraductal papillary mucinous neoplasm of the pancreas].
    Butte JM; Torres J; O'Brien A; Jarufe N; Llanos O
    Rev Med Chil; 2008 Apr; 136(4):517-27. PubMed ID: 18769796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of intraductal papillary mucinous neoplasms.
    Crippa S; Fernández-del Castillo C
    Curr Gastroenterol Rep; 2008 Apr; 10(2):136-43. PubMed ID: 18462599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
    Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of branch-duct intraductal papillary mucinous neoplasms of the pancreas: a case report.
    Casadei R; Ricci C; D'Ambra M; Taffurelli G; Zingaretti CC; Pacilio CA; Calculli L; Pagano N; Minni F
    JOP; 2014 Jul; 15(4):391-3. PubMed ID: 25076351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas.
    Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    Surgery; 2016 Aug; 160(2):306-17. PubMed ID: 27236360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant Intraductal Papillary Mucinous Neoplasia (IPMN) of the Pancreas with Malignant Degeneration.
    Nassenstein K; Markus P; Schumacher B
    Dtsch Arztebl Int; 2019 Mar; 116(11):193. PubMed ID: 31014455
    [No Abstract]   [Full Text] [Related]  

  • 36. Colloid Carcinoma of Pancreas in the Setting of Intraductal Papillary Mucinous Neoplasm (IPMN).
    Jayakrishnan T; Pandya D; Monga D
    J Gastrointest Cancer; 2020 Jun; 51(2):658-662. PubMed ID: 31811471
    [No Abstract]   [Full Text] [Related]  

  • 37. A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
    Ghaneh P; Neoptolemos J
    Gut; 2007 Aug; 56(8):1041-4. PubMed ID: 17625140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intraductal papillary mucinous neoplasia of the pancreas].
    Cienfuegos JA; Rotellar F
    Rev Esp Enferm Dig; 2012 Feb; 104(2):98. PubMed ID: 22372806
    [No Abstract]   [Full Text] [Related]  

  • 39. Pancreatic duct lavage cytology for the diagnosis of branch duct-type intraductal papillary mucinous neoplasm of the pancreas.
    Sai JK; Suyama M; Kubokawa Y; Watanabe S
    Pancreas; 2008 Mar; 36(2):216-7. PubMed ID: 18376321
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.